FGF-2 targeted adenovirus (Selective Genetics)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameFGF-2 targeted adenovirus (Selective Genetics)
Drug Alias NameDirectinFGF-2 gene therapy (Selective Genetics)FGF-2 targeted adenovirus (Prizm)GAM (Selective Genetics)tGAMS (Selective Genetics) +[8] 
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsWounds and InjuriesIschemiaOvarian Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSelective Genetics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSelective Genetics Inc
Active IndicationsN/A
Inactive IndicationsWounds and InjuriesIschemiaOvarian Neoplasms +[5] 

Other Information

ATC CodeN/A
Related LinksN/A